Cell Reports
Volume 7, Issue 4, 22 May 2014, Pages 1239-1247
Journal home page for Cell Reports

Article
The Histone Methyltransferase Activity of MLL1 Is Dispensable for Hematopoiesis and Leukemogenesis

https://doi.org/10.1016/j.celrep.2014.04.015Get rights and content
Under a Creative Commons license
open access

Highlights

  • The MLL1 SET domain is not necessary for hematopoietic target gene regulation

  • The endogenous MLL1 HMT activity is not needed for MLL-AF9 transformation

  • MOF-mediated H4K16Ac at hematopoietic MLL1 target genes is critical for expression

  • SIRT1 is a specific antagonist for MLL1 gene activation in hematopoietic cells

Summary

Despite correlations between histone methyltransferase (HMT) activity and gene regulation, direct evidence that HMT activity is responsible for gene activation is sparse. We address the role of the HMT activity for MLL1, a histone H3 lysine 4 (H3K4) methyltransferase critical for maintaining hematopoietic stem cells (HSCs). Here, we show that the SET domain, and thus HMT activity of MLL1, is dispensable for maintaining HSCs and supporting leukemogenesis driven by the MLL-AF9 fusion oncoprotein. Upon Mll1 deletion, histone H4 lysine 16 (H4K16) acetylation is selectively depleted at MLL1 target genes in conjunction with reduced transcription. Surprisingly, inhibition of SIRT1 is sufficient to prevent the loss of H4K16 acetylation and the reduction in MLL1 target gene expression. Thus, recruited MOF activity, and not the intrinsic HMT activity of MLL1, is central for the maintenance of HSC target genes. In addition, this work reveals a role for SIRT1 in opposing MLL1 function.

Cited by (0)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).